Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosing of Carcinogenic Complexes Such as Urinary O-toluidine and Hemoglobin Adducts From O-toluidine in Blood After Intrathecal Administration of 50 mg Hyperbaric Prilocaine

NCT03642301 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Saint Pierre as lead sponsor.

NCT NCT03642301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03642301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosing of Carcinogenic Complexes Such as Urinary O-toluidine and Hemoglobin Adducts From O-toluidine in Blood After Intrathecal Administration of 50 mg Hyperbaric Prilocaine
Lead sponsor
Centre Hospitalier Universitaire Saint Pierre
Phase
Observational
Overall status
Completed
Start date
January 10, 2019
Completion date
March 27, 2019
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia